SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-18-002896
Filing Date
2018-11-13
Accepted
2018-11-13 06:13:58
Documents
43
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q zk1822241.htm 10-Q 671129
2 EXHIBIT 31.2 exhibit_31-2.htm EX-31.2 14097
3 EXHIBIT 32.1 exhibit_32-1.htm EX-32.1 6674
  Complete submission text file 0001178913-18-002896.txt   2327458

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT atms-20180930.xml EX-101.INS 371091
5 XBRL TAXONOMY EXTENSION SCHEMA atms-20180930.xsd EX-101.SCH 27910
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atms-20180930_cal.xml EX-101.CAL 26782
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atms-20180930_def.xml EX-101.DEF 86656
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE atms-20180930_lab.xml EX-101.LAB 167562
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atms-20180930_pre.xml EX-101.PRE 134285
Mailing Address 18 EAST 16TH STREET NEW YORK NY 10003
Business Address 18 EAST 16TH STREET NEW YORK NY 10003 646-233-1454
Artemis Therapeutics, Inc. (Filer) CIK: 0001062128 (see all company filings)

IRS No.: 841417774 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24431 | Film No.: 181174721
SIC: 2890 Miscellaneous Chemical Products
Assistant Director 6